Post-Brexit medicines regulation must have international scope

Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left behind.

If the UK creates regulatory frameworks that drastically diverge from those of its “science allies”, it could become a late – or even no – launch market for new treatments.

Read the source article at pharmaphorum.com
2021-12-09 12:24:41